Article information
Abstract
Viral infections are a major cause of morbidity and even mortality in solid organ transplant recipients. This article reviews key aspects of infections in solid organ transplant recipients from respiratory viruses, such as influenza, polyomavirus, erythrovirus B19 and measles.
Keywords:
Erythrovirus B19
Influenza
Measles
Polyomavirus
Respiratory virus
Solid organ transplantation
Resumen
Las infecciones víricas constituyen una causa importante de morbilidad y, en ocasiones, también de mortalidad en el receptor de un trasplante de órgano sólido. En este artículo se revisan aspectos fundamentales acerca de las infecciones por virus respiratorios, incluyendo el virus de la gripe, poliomavirus, erythrovirus B19 y sarampión en el receptor de un trasplante de órgano sólido.
Palabras clave:
Erythrovirus B19
Gripe
Poliomavirus
Sarampión
Trasplante de órgano sólido
Virus respiratorios
Full text is only aviable in PDF
References
[1.]
R.A. Vilchez, K. McCurry, J. Dauber, A. Lacono, B. Griffith, J. Fung, et al.
Influenza virus infection in adult solid organ transplant recipients.
Am J Transplant, 2 (2002), pp. 287-291
[2.]
C.Y. Low, T. Kee, K.P. Chan, L.L. Oon, C.K. Tan, N.W. Tee, et al.
Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore.
Transplantation, 90 (2010), pp. 1016-1021
[3.]
D. Kumar, M.G. Michaels, M.I. Morris, M. Green, R.K. Avery, C. Liu, et al.
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.
Lancet Infect Dis, 10 (2010), pp. 521-526
[4.]
A. Smud, C.B. Nagel, E. Madsen, M.C. Rial, L.A. Barcán, A.A. Gómez, et al.
Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study.
Transplantation, 90 (2010), pp. 1458-1462
[5.]
E. Cordero, P. Pérez-Romero, A. Moreno, O. Len, M. Montejo, E. Vidal, et al.
Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection.
Clin Microbiol Infect, (2011),
[6.]
P. Ljungman, J. Andersson, J. Aschan, L. Barkholt, A. Ehrnst, M. Johansson, et al.
Influenza A in immunocompromised patients.
Clin Infect Dis, 17 (1993), pp. 244-247
[7.]
Anonymous.
Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009.
MMWR Morb Mortal Wkly Rep, 58 (2010), pp. 1436-1440
[8.]
D. Viasus, J.R. Paño-Pardo, J. Pachón, A. Campins, F. López-Medrano, A. Villoslada, et al.
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain.
Clin Microbiol Infect, 17 (2011), pp. 738-746
[9.]
E. Cordero, T. Aydillo, M.C. Fariñas, J.R. Paño-Pardo, J. Pachón, D. Viasus, et al.
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.
Eur J Clin Microbiol Infect Dis, (2011),
[10.]
A. Campbell, R. Rodin, R. Kropp, Y. Mao, Z. Hong, J. Vachon, et al.
Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.
CMAJ, 182 (2010), pp. 349-355
[11.]
S. Hackett, L. Hill, J. Patel, N. Ratnaraja, A. Ifeyinwa, M. Farooqi, et al.
Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK.
Lancet, 374 (2009), pp. 605
[12.]
F.P. Hurst, J.J. Lee, R.M. Jindal, L.Y. Agodoa, K.C. Abbott.
Outcomes associated with influenza vaccination in the first year after kidney transplantation.
Clin J Am Soc Nephrol, 6 (2011), pp. 1192-1197
[13.]
D. Kumar, E.A. Blumberg, L. Danziger-Isakov, C.N. Kotton, N.B. Halasa, M.G. Ison, et al.
Influenza vaccination in the organ transplant recipient: review and summary recommendations.
Am J Transplant, 11 (2011), pp. 2020-2030
[14.]
K.A. Birdwell, M.R. Ikizler, E.C. Sannella, L. Wang, D.W. Byrne, T.A. Ikizler, et al.
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.
Am J Kidney Dis, 54 (2009), pp. 112-121
[15.]
O. Manuel, M. Pascual, K. Hoschler, S. Giulieri, D. Alves, K. Ellefsen, et al.
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.
Clin Infect Dis, 52 (2011), pp. 248-256
[16.]
S. Meyer, M. Adam, B. Schweiger, C. Ilchmann, C. Eulenburg, E. Sattinger, et al.
Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
Transplantation, 91 (2011), pp. 1031-1035
[17.]
E. Cordero, A. Pérez-Ordóñez, T.A. Aydillo, J. Torre-Cisneros, J. Gavaldà, R. Lara, et al.
Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients.
Am J Transplant, 11 (2011), pp. 2205-2213
[18.]
M.G. Ison.
Respiratory viral infections in transplant recipients.
Antivir Ther, 12 (2007), pp. 627-638
[19.]
S.A. Fischer.
Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.
Transplantation, 86 (2008), pp. 1327-1339
[20.]
F. López-Medrano, J.M. Aguado, M. Lizasoain, D. Folgueira, R. San Juan, C. Díaz-Pedroche, et al.
Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.
Transplantation, 84 (2007), pp. 851-856
[21.]
C.B. Hall.
Nosocomial respiratory syncytial virus infections: the “cold war” has not ended.
Clin Infect Dis, 31 (2000), pp. 590-596
[22.]
J.A. Hoffman.
Adenovirus infections in solid organ transplant recipients.
Curr Opin Organ Transplant, 14 (2009), pp. 625-633
[23.]
J. Garbino, P.M. Soccal, J.D. Aubert, T. Rochat, P. Meylan, Y. Thomas, et al.
Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults.
Thorax, 64 (2009), pp. 399-404
[24.]
S. Kusne, J.S. Dummer, N. Singh, S. Iwatsuki, L. Makowka, C. Esquivel, et al.
Infections after liver transplantation. An analysis of 101 consecutive cases.
Medicine (Baltimore), 67 (1988), pp. 132-143
[25.]
J.A. Englund.
Diagnosis and epidemiology of community-acquired respiratory virus infections in the immunocompromised host.
Biol Blood Marrow Transplant, 7 (2001), pp. 2S-4S
[26.]
A.M. Apalsch, M. Green, J. Ledesma-Medina, B. Nour, E.R. Wald.
Parainfluenza and influenza virus infection in pediatric organ transplant recipients.
Clin Infect Dis, 20 (1995), pp. 394-399
[27.]
L. Kaiser, J.D. Aubert, J.C. Pache, C. Deffernez, T. Rochat, J. Garbino, et al.
Chronic rhinoviral infection in lung transplant recipients.
Am J Respir Crit Care Med, 174 (2006), pp. 1392-1399
[28.]
M. Camps Serra, C. Cervera, T. Pumarola, A. Moreno, R. Perelló, A. Torres, et al.
Virological diagnosis in community-acquired pneumonia in immunocompromised patients.
Eur Respir J, 31 (2008), pp. 618-624
[29.]
G. Gerna, A. Piralla, F. Rovida, V. Rognoni, A. Marchi, F. Locatelli, et al.
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients.
J Med Virol, 81 (2009), pp. 1498-1507
[30.]
W.G. Nichols, A.J. Peck Campbel, M. Boeckh.
Respiratory viruses other than influenza virus: impact and therapeutic advances.
Clin Microbiol Rev, 21 (2008), pp. 274-290
[31.]
L.H. McCurdy, A. Milstone, S. Dummer.
Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
J Heart Lung Transplant, 22 (2003), pp. 745-753
[32.]
G. Siegl, R.C. Bates, K.I. Berns, B.J. Carter, D.C. Kelly, E. Kustak, et al.
Characteristics and taxonomy of Parvoviridae.
Intervirology, 23 (1985), pp. 61-73
[33.]
H.A. Kelly, D. Siebert, R. Hammond, J. Leydon, P. Kiely, W. Maskill.
The age-specific prevalence of human erythrovirus immunity in Victoria. Australia compared with other parts of the world.
Epidemiol Infect, 124 (2000), pp. 449-457
[34.]
P. Norja, A.M. Eis-Hübinger, M. Söderlund-Venermo, K. Hedman, P. Simmonds.
Rapid sequence change and geographical spread of human erythrovirus B19: comparison of B19 virus evolution in acute and persistent infections.
J Virol, 82 (2008), pp. 6427-6433
[35.]
R.Z. Zolnourian, M.D. Curran, B.K. Rima, P.V. Coyle, H.J. O’Neill, D. Middleton.
Erythrovirus B19 in kidney transplant patients.
Transplantation, 69 (2000), pp. 2198-2202
[36.]
C.S. Ki, I.S. Kim, J.W. Kim, N.Y. Lee, S.H. Kim, K.W. Lee, et al.
Incidence and clinical significance of human erythrovirus B19 infection in kidney transplant recipients.
Clin Tranplant, 19 (2005), pp. 751-755
[37.]
P.A. Rota, K. Brown, A. Mankertz, S. Santibanez, S. Shulga, C.P. Muller, et al.
Global distribution of measles genotypes and measles molecular epidemiology.
J Infect Dis, 204 (2011), pp. S514-S523
[38.]
R.D. Wong, M.B. Goetz.
Clinical and laboratory features of measles in hospitalized adults.
Am J Med, 95 (1993), pp. 377-383
[39.]
T. Sternfeld, V. Spöri-Byrtus, C. Riediger, R. Langer, H. Friess, R.M. Schmid, et al.
Acute measles infection triggering an episode of liver transplant rejection.
Int J Infect Dis, 14 (2010), pp. e528-e530
[40.]
E. Csoma, B. Mészáros, L. Asztalos, J. Kónya, L. Gergely.
Prevalence of WU and KI polyomaviruses in plasma, urine, and respiratory samples from renal transplant patients.
J Med Virol, 83 (2011), pp. 1275-1278
[41.]
C.S. Tan, I.J. Koralnik.
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Lancet Neurol, 9 (2010), pp. 425-437
[42.]
R.T. Neff, F.P. Hurst, E.M. Falta, E.M. Bohen, K.L. Lentine, V.R. Dharnidharka, et al.
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.
Transplantation, 86 (2008), pp. 1474-1478
[43.]
X. Verhelst, G. Vanhooren, L. Vanopdenbosch, J. Casselman, W. Laleman, J. Pirenne, et al.
Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.
Transplant Int, 24 (2011), pp. e30-e34
[44.]
N. Kamar, C. Mengelle, L. Rostaing.
Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients.
Am J Transplant, 9 (2009), pp. 244-245
[45.]
M. Fernández-Ruiz, J. De la Serna, J. Ruiz, F. López-Medrano.
Leucoencefalopatía multifocal progresiva en un paciente con leucemia mieloide aguda sometido a trasplante alogénico de progenitores hematopoyéticos.
Enferm Infecc Microbiol Clin, 28 (2011), pp. 636-637
[46.]
T.E. Gofton, A. Al-Khotani, B. O’Farrell, L.C. Ang, R.S. McLachlan.
Mefloquine in the treatment of progressive multifocal leukoencephalopathy.
J Neurol Neurosurg Psychiatry, 82 (2011), pp. 452-455
[47.]
H.H. Hirsch, P. Randhawa.
BK virus in solid organ transplant recipients.
Am J Transplant, 9 (2009), pp. S136-S146
[48.]
O. Prince, S. Savic, M. Dickenmann, J. Steiger, L. Bubendorf, M.J. Mihatsch.
Risk factors for polyoma virus nephropathy.
Nephrol Dial Transplant, 24 (2009), pp. 1024-1033
[49.]
C.B. Drachenberg, J.C. Papadimitriou, H.H. Hirsch, R. Wali, C. Crowder, J. Nogueira, et al.
Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load.
Am J Transplant, 4 (2004), pp. 2082-2092
[50.]
C. Alméras, F. Vetromile, V. Garrigue, I. Szwarc, V. Foulongne, G. Mourad.
Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.
Transplant Infect Dis, 13 (2011), pp. 101-108
[51.]
S. Gabardi, S.S. Waikar, S. Martin, K. Roberts, J. Chen, L. Borgi, et al.
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.
Clin J Am Soc Nephrol, 5 (2010), pp. 1298-1304
[52.]
D. Geetha, S.M. Sozio, M. Ghanta, M. Josephson, R. Shapiro, D. Dadhania, et al.
Results of repeat renal transplantation after graft loss from BK virus nephropathy.
Transplantation, 92 (2011), pp. 781-786
Copyright © 2012. Elsevier España S.L.. All rights reserved
